cro_thumnail_2.jpg

Article - January 30, 2023

To become more efficient in research and development and maximize their returns on approved therapies, pharmaceutical companies are outsourcing more functional areas. That's creating opportunities for strategic buyers and private equity investors.

In this article series, professionals from the Harris Williams Healthcare & Life Sciences Group and Technology Group discuss the specific areas within outsourced pharmaceutical services offering buyer upside—and the strategies that can unlock potential.

Contact our senior bankers to learn more about our experience in the outsourced pharma services sector.